US Stock MarketDetailed Quotes

PASG Passage Bio

Watchlist
  • 1.200
  • -0.070-5.51%
Close Apr 18 16:00 ET
  • 1.200
  • 0.0000.00%
Post 19:23 ET
73.93MMarket Cap-645P/E (TTM)

About Passage Bio Company

Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.

Company Profile

SymbolPASG
Company NamePassage Bio
Listing DateFeb 28, 2020
Issue Price18.00
Founded2017
CEODr. William Chou, M.D.
MarketNASDAQ
Employees58
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressOne Commerce Square,2005 Market Street,39th floor
CityPhiladelphia
ProvincePennsylvania
CountryUnited States of America
Zip Code19103
Phone1-267-866-0311
Websitehttp://www.passagebio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. William Chou, M.D.
  • President, Chief Executive Officer and Director
  • 1.45M
  • Mark S. Forman
  • Chief Medical Officer
  • 1.01M
  • Kathleen Borthwick
  • Senior Vice President, Principal Accounting Officer and Chief Financial Officer
  • --
  • Sandip S. Kapadia, C.P.A.,M.B.A.
  • Independent Director
  • 73.34K
  • Dr. Dolan Sondhi, PhD
  • Independent Director
  • 49.90K
  • Dr. Athena Countouriotis, M.D.
  • Independent Director
  • 69.97K
  • Dr. Derrell D. Porter, M.D.
  • Independent Director
  • 69.30K
  • Saqib Islam, J.D.
  • Independent Director
  • 65.84K
  • Edgar B. Cale
  • General Counsel and Corporate Secretary
  • 949.73K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg